Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bausch & Lomb Corp (BLCO)

Bausch & Lomb Corp (BLCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,873,423
  • Shares Outstanding, K 356,397
  • Annual Sales, $ 5,101 M
  • Annual Income, $ -360,000 K
  • EBIT $ 371 M
  • EBITDA $ 810 M
  • 60-Month Beta 0.65
  • Price/Sales 1.16
  • Price/Cash Flow 9.91
  • Price/Book 0.90
  • Price/Earnings ttm 33.08
  • Earnings Per Share ttm 0.50
  • Most Recent Earnings $0.32 on 02/18/26
  • Next Earnings Date 04/29/26 [BMO]
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING:

    SIC-3851 Ophthalmic Goods

    Medical Services

Options Overview Details

View History
  • Implied Volatility 52.25% (+1.52%)
  • Historical Volatility 37.95%
  • IV Percentile 27%
  • IV Rank 11.39%
  • IV High 187.31% on 11/19/25
  • IV Low 34.89% on 12/23/25
  • Expected Move (DTE 7) 0.77 (4.69%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 16
  • Volume Avg (30-Day) 169
  • Put/Call OI Ratio 0.08
  • Today's Open Interest 4,283
  • Open Int (30-Day) 3,909
  • Expected Range 15.72 to 17.26

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $0.06
  • Number of Estimates 5
  • High Estimate $0.14
  • Low Estimate $0.02
  • Prior Year $-0.07
  • Growth Rate Est. (year over year) +185.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.14 +8.92%
on 03/30/26
17.68 -6.73%
on 03/11/26
-0.63 (-3.68%)
since 03/10/26
3-Month
15.14 +8.92%
on 03/30/26
18.92 -12.82%
on 02/25/26
-0.72 (-4.18%)
since 01/09/26
52-Week
10.45 +57.80%
on 04/30/25
18.92 -12.82%
on 02/25/26
+5.17 (+45.67%)
since 04/10/25

Most Recent Stories

More News
3 Cash-Burning Stocks We Keep Off Our Radar

3 Cash-Burning Stocks We Keep Off Our Radar

DCO : 139.99 (-0.43%)
BLCO : 16.49 (+0.06%)
BYRN : 5.68 (-10.48%)
Bausch + Lomb Receives FDA 510(k) Clearance for Bi-Blade+™ Dual-Port Vitrectomy Cutter and Adaptive Fluidics™ Advanced Update

Increased cutting speed of 25,000 cuts per minute 1 is designed to minimize retinal traction, 2 increase vitreous flow, 1 and reduce infusion pressure...

BLCO.TO : 22.83 (+0.57%)
BLCO : 16.49 (+0.06%)
1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off

1 Healthcare Stock with Solid Fundamentals and 2 We Brush Off

INSP : 54.02 (-4.71%)
BLCO : 16.49 (+0.06%)
DHR : 189.61 (-1.75%)
Bausch + Lomb Launches Preloaded enVista Envy™ Full Range of Vision Intraocular Lenses in Europe

enVista Envy is the first diffractive premium IOL from Bausch + Lomb available in Europe Offers a continuous range of vision with excellent dysphotopsia...

BLCO.TO : 22.83 (+0.57%)
BLCO : 16.49 (+0.06%)
Bausch + Lomb Announces New Scientific Data, Educational Events at the American Society of Cataract and Refractive Surgery Annual Meeting

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the presentation of new scientific data and events...

BLCO.TO : 22.83 (+0.57%)
BLCO : 16.49 (+0.06%)
Q4 Rundown: Bausch + Lomb (NYSE:BLCO) Vs Other Medical Devices & Supplies - Specialty Stocks

Q4 Rundown: Bausch + Lomb (NYSE:BLCO) Vs Other Medical Devices & Supplies - Specialty Stocks

BLCO : 16.49 (+0.06%)
Bausch + Lomb Will Release First-Quarter 2026 Financial Results on April 29

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, will release its first-quarter financial results on Wednesday, April...

BLCO.TO : 22.83 (+0.57%)
BLCO : 16.49 (+0.06%)
3 Reasons BLCO is Risky and 1 Stock to Buy Instead

3 Reasons BLCO is Risky and 1 Stock to Buy Instead

BLCO : 16.49 (+0.06%)
Bausch + Lomb Announces Positive 24-Month U.S. Data on the ELIOS™ System for Treatment of Glaucoma

Both primary effectiveness endpoints were met, demonstrating statistically significant and clinically meaningful intraocular pressure reduction. ELIOS is an implant-free procedure that...

BLCO.TO : 22.83 (+0.57%)
BLCO : 16.49 (+0.06%)
Bausch + Lomb Launches R&D “Teach-in” Webinar Series

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the first event in an R&D “Teach-in” webinar series...

BLCO.TO : 22.83 (+0.57%)
BLCO : 16.49 (+0.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Bausch Lomb Corporation is an eye health company. Its product portfolio includes Biotrue(R) and renu(R) multi-purpose solutions, Biotrue(R) ONEday daily disposable contact lenses, LUMIFY(R) redness reliever eye drops, PreserVision(R) AREDS 2 formula eye vitamin and mineral supplements and VYZULTA(R)....

See More

Key Turning Points

3rd Resistance Point 16.91
2nd Resistance Point 16.78
1st Resistance Point 16.63
Last Price 16.49
1st Support Level 16.35
2nd Support Level 16.22
3rd Support Level 16.07

See More

52-Week High 18.92
Last Price 16.49
Fibonacci 61.8% 15.68
Fibonacci 50% 14.68
Fibonacci 38.2% 13.68
52-Week Low 10.45

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.